PERSPECTA

News from every angle

← Back to headlines

Ocular Therapeutix Stock Rises Following Rival's AMD Trial Setback

Shares of Ocular Therapeutix increased after a competitor's clinical trial for wet AMD encountered difficulties, impacting its stock performance.

17 Aug, 14:25 — 17 Aug, 14:25
PostShare

Sources

Showing 1 of 1 sources
investing-com2h ago

Ocular Therapeutix stock rises as rival’s wet AMD trial stumbles By Investing.com - Investing.com South Africa

Ocular Therapeutix stock rises as rival’s wet AMD trial stumbles By Investing.com  Investing.com South Africa

Read full article →

Related Stories

Transpay Application Opens for Publicizing Agricultural Aid Payments

23m ago

Ferrari's First Electric Car Sells for Record $40 Million at Auction

26m ago

Multiple Companies Release Q2 and Q4 2026 Earnings Call Transcripts

26m ago

Uber and Zipline Partner for US Drone Delivery Service

26m ago